Sexual HealthPT-141
10MG
$60
Description
PT-141 (Bremelanotide) is a synthetic melanocortin peptide derived from Melanotan-2, specifically developed to target sexual function. Unlike PDE5 inhibitors that work on vascular blood flow, PT-141 works directly in the central nervous system by activating melanocortin-4 receptors (MC4R) in the brain, stimulating the neural pathways responsible for sexual arousal and desire. This unique mechanism of action means PT-141 addresses the neurological component of sexual function, making it effective for both men and women in research settings. It was FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Potential Benefits
Research Notes
Clinical trials published in the Journal of Sexual Medicine led to FDA approval of bremelanotide (Vyleesi) in 2019 for HSDD in premenopausal women. Studies in men demonstrated significant improvements in erectile function. PT-141's unique CNS-mediated mechanism, working through MC4R activation in the hypothalamus, represents a fundamentally different approach to sexual health research compared to vascular-targeted compounds.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.